bioAffinity Technologies, Inc. – Trademark Portfolio

Entity Type: 03

bioAffinity Technologies, Inc. owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CYPATH, ONCOSELECT, BIOAFFINITY, and BIOAFFINITY TECHNOLOGIES. Of these, 7 are registered and 3 are pending. The portfolio spans 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 10 (Medical Apparatus). Headquartered in San Antonio, TX.